ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0814
-0,02%
Bitcoin
69.318,14
-0,02%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Checkpoint Therapeutics Inc (CKPT)

  7. Checkpoint Therapeutics Inc (CKPT) News

CKPT

Checkpoint Therapeutics (CKPT)

Checkpoint Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CKPT
DatumZeitQuelleÜberschriftSymbolFirma
25/05/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
25/05/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
25/05/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
25/05/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202422h06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CKPTCheckpoint Therapeutics Inc
17/05/202401h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
14/05/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
10/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
10/05/202414h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
02/03/202402h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
05/02/202423h00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CKPTCheckpoint Therapeutics Inc
03/02/202402h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CKPTCheckpoint Therapeutics Inc
02/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
30/01/202423h10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CKPTCheckpoint Therapeutics Inc
30/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
05/01/202423h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
18/12/202313h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
27/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CKPTCheckpoint Therapeutics Inc
17/11/202323h02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CKPTCheckpoint Therapeutics Inc
17/11/202323h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CKPTCheckpoint Therapeutics Inc
13/11/202323h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
13/11/202323h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
03/10/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202322h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
14/08/202322h01GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:CKPTCheckpoint Therapeutics Inc
31/07/202314h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
31/07/202314h23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CKPTCheckpoint Therapeutics Inc
27/07/202313h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CKPTCheckpoint Therapeutics Inc
24/05/202323h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CKPTCheckpoint Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CKPT

Kürzlich von Ihnen besucht

LSE
34XG
Nationwde. 25 S
KUCN
PIPUSDT
PIP
EU
0973T
0973T
BIT
UC72PL
Unicredit Bank
ASX
BXBIST
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten